AT324338B - Verfahren zur herstellung von neuen 2,6-diamino-dihydropyridinen - Google Patents
Verfahren zur herstellung von neuen 2,6-diamino-dihydropyridinenInfo
- Publication number
- AT324338B AT324338B AT197373A AT197373A AT324338B AT 324338 B AT324338 B AT 324338B AT 197373 A AT197373 A AT 197373A AT 197373 A AT197373 A AT 197373A AT 324338 B AT324338 B AT 324338B
- Authority
- AT
- Austria
- Prior art keywords
- dihydropyridines
- diamino
- producing new
- producing
- new
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2210687A DE2210687C3 (de) | 1972-03-06 | 1972-03-06 | 2,6-Diamino-3,5-diäthoxycarbonyldihydropyridine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AT324338B true AT324338B (de) | 1975-08-25 |
Family
ID=5838037
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT197373A AT324338B (de) | 1972-03-06 | 1973-03-06 | Verfahren zur herstellung von neuen 2,6-diamino-dihydropyridinen |
| AT925774*7A AT327904B (de) | 1972-03-06 | 1973-03-06 | Verfahren zur herstellung von neuen 2,6-diamino-dihydropyridinen |
| AT925774A ATA925774A (de) | 1972-03-06 | 1973-03-06 | Verfahren zur herstellung von neuen 2,6-diamino-dihydropyridinen |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT925774*7A AT327904B (de) | 1972-03-06 | 1973-03-06 | Verfahren zur herstellung von neuen 2,6-diamino-dihydropyridinen |
| AT925774A ATA925774A (de) | 1972-03-06 | 1973-03-06 | Verfahren zur herstellung von neuen 2,6-diamino-dihydropyridinen |
Country Status (24)
| Country | Link |
|---|---|
| JP (2) | JPS5626659B2 (ro) |
| KR (1) | KR780000119B1 (ro) |
| AT (3) | AT324338B (ro) |
| BE (1) | BE796279A (ro) |
| BG (2) | BG22815A3 (ro) |
| CA (1) | CA988524A (ro) |
| CH (2) | CH577473A5 (ro) |
| CS (2) | CS182781B2 (ro) |
| DD (1) | DD106833A5 (ro) |
| DE (1) | DE2210687C3 (ro) |
| DK (1) | DK136061C (ro) |
| ES (1) | ES412323A1 (ro) |
| FI (1) | FI55996C (ro) |
| FR (1) | FR2181789B1 (ro) |
| GB (1) | GB1379005A (ro) |
| HU (1) | HU167089B (ro) |
| IE (1) | IE37370B1 (ro) |
| IL (1) | IL41664A (ro) |
| LU (1) | LU67147A1 (ro) |
| NL (1) | NL7303137A (ro) |
| PL (2) | PL92078B1 (ro) |
| RO (2) | RO63068A (ro) |
| SE (1) | SE384208B (ro) |
| ZA (1) | ZA731501B (ro) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2210687C3 (de) * | 1972-03-06 | 1981-09-24 | Bayer Ag, 5090 Leverkusen | 2,6-Diamino-3,5-diäthoxycarbonyldihydropyridine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel |
| DE2406198C2 (de) * | 1974-02-09 | 1983-12-15 | Bayer Ag, 5090 Leverkusen | Verfahren zur Herstellung von neuen 2-Amino-6-dialkylamino-dihydropyridinen |
| JPS5922593U (ja) * | 1982-08-03 | 1984-02-10 | 日本マランツ株式会社 | ヘツドホ−ン用ホ−ン部取付構造 |
| JPS5922594U (ja) * | 1982-08-03 | 1984-02-10 | 日本マランツ株式会社 | 耳栓型ヘツドホ−ン |
| JPS6282898A (ja) * | 1985-10-08 | 1987-04-16 | Matsushita Electric Ind Co Ltd | ヘツドホン |
| JPS6293060U (ro) * | 1985-11-28 | 1987-06-13 | ||
| AU2021387535A1 (en) * | 2020-11-30 | 2023-07-06 | George Kanianthara Chandy | POTENT AND SELECTIVE INHIBITORS OF THE CALCIUM-ACTIVATED POTASSIUM CHANNEL, KCa3.1, FOR USE AS PLATFORM THERAPEUTICS |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2210687C3 (de) * | 1972-03-06 | 1981-09-24 | Bayer Ag, 5090 Leverkusen | 2,6-Diamino-3,5-diäthoxycarbonyldihydropyridine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel |
| US3855231A (en) * | 1972-03-06 | 1974-12-17 | Bayer Ag | 2,6-diamino-1,4-dihydropyridine derivatives |
| DE2406198C2 (de) * | 1974-02-09 | 1983-12-15 | Bayer Ag, 5090 Leverkusen | Verfahren zur Herstellung von neuen 2-Amino-6-dialkylamino-dihydropyridinen |
-
1972
- 1972-03-06 DE DE2210687A patent/DE2210687C3/de not_active Expired
-
1973
- 1973-02-13 RO RO7300082647A patent/RO63068A/ro unknown
- 1973-02-13 RO RO73832A patent/RO61192A/ro unknown
- 1973-02-26 DD DD169048A patent/DD106833A5/xx unknown
- 1973-02-28 BG BG022858A patent/BG22815A3/xx unknown
- 1973-02-28 BG BG024472A patent/BG20583A3/xx unknown
- 1973-03-02 IL IL7341664A patent/IL41664A/en unknown
- 1973-03-02 FI FI657/73A patent/FI55996C/fi active
- 1973-03-02 LU LU67147A patent/LU67147A1/xx unknown
- 1973-03-02 CH CH220176A patent/CH577473A5/xx not_active IP Right Cessation
- 1973-03-02 CH CH313273A patent/CH580589A5/xx not_active IP Right Cessation
- 1973-03-02 JP JP2445273A patent/JPS5626659B2/ja not_active Expired
- 1973-03-03 PL PL1973182270A patent/PL92078B1/pl unknown
- 1973-03-03 PL PL1973161010A patent/PL89256B1/pl unknown
- 1973-03-05 IE IE346/73A patent/IE37370B1/xx unknown
- 1973-03-05 KR KR7300356A patent/KR780000119B1/ko not_active Expired
- 1973-03-05 SE SE7303021A patent/SE384208B/xx unknown
- 1973-03-05 ZA ZA731501A patent/ZA731501B/xx unknown
- 1973-03-05 DK DK118073A patent/DK136061C/da active
- 1973-03-05 CA CA165,209A patent/CA988524A/en not_active Expired
- 1973-03-05 BE BE128374A patent/BE796279A/xx not_active IP Right Cessation
- 1973-03-05 ES ES412323A patent/ES412323A1/es not_active Expired
- 1973-03-06 FR FR7307923A patent/FR2181789B1/fr not_active Expired
- 1973-03-06 AT AT197373A patent/AT324338B/de not_active IP Right Cessation
- 1973-03-06 HU HUBA2892A patent/HU167089B/hu unknown
- 1973-03-06 AT AT925774*7A patent/AT327904B/de not_active IP Right Cessation
- 1973-03-06 GB GB1075973A patent/GB1379005A/en not_active Expired
- 1973-03-06 CS CS7300001593A patent/CS182781B2/cs unknown
- 1973-03-06 CS CS7500003602A patent/CS182792B2/cs unknown
- 1973-03-06 NL NL7303137A patent/NL7303137A/xx not_active Application Discontinuation
- 1973-03-06 AT AT925774A patent/ATA925774A/de unknown
-
1980
- 1980-12-27 JP JP55185147A patent/JPS5911584B2/ja not_active Expired
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AT331258B (de) | Verfahren zur herstellung von neuen 1,2,3-oxathiazin-4-onen | |
| ATA779373A (de) | Verfahren zur herstellung von neuen a-phenylindolderivaten | |
| AT342556B (de) | Verfahren zur herstellung von neuen 1,2,2,2-tetrafluorathylathern | |
| AT327904B (de) | Verfahren zur herstellung von neuen 2,6-diamino-dihydropyridinen | |
| AT328078B (de) | Verfahren zur herstellung von neuen cyanomethylthioacetylcephalosporinen | |
| AT331806B (de) | Verfahren zur herstellung von neuen 1,2,4-triazin-di-n-oxiden(1,4) | |
| AT324330B (de) | Verfahren zur herstellung von neuen sulfonylverbindungen | |
| AT342564B (de) | Verfahren zur herstellung von neuen 11,12-secoprostaglandinen | |
| AT327902B (de) | Verfahren zur herstellung von neuen 3,4-dihydropyridonen | |
| AT327407B (de) | Verfahren zur herstellung von neuen benzomorphanderivaten | |
| AT326842B (de) | Verfahren zur herstellung von neuen 9,10-secoöstran-derivaten | |
| AT328459B (de) | Verfahren zur herstellung von neuen 1,3,5-triazinen | |
| AT326841B (de) | Verfahren zur herstellung von neuen 15alfa,16alfa-methylen-4-pregnenen | |
| AT326145B (de) | Verfahren zur herstellung von neuen phosphonoureidoverbindungen | |
| AT322104B (de) | Verfahren zur herstellung von neuen pyrono-rifamycinen | |
| AT322739B (de) | Verfahren zur herstellung von neuen 8-oxo-thia-l-aza-bicyclo(4,2,0)oct-2-en-verbindungen | |
| AT323885B (de) | Verfahren zur herstellung von neuen 3-formylrifamycinazinen | |
| AT331203B (de) | Verfahren zur herstellung von 1,2-dichlorathan | |
| AT328631B (de) | Verfahren zur herstellung von neuen 9,10-seco-ostran-derivaten | |
| AT323345B (de) | Verfahren zur herstellung von neuen 15 alfa, 16 alfa-methylen-5 alfa-androstanen | |
| AT342025B (de) | Verfahren zur herstellung von neuen 2- (alfa-di-substituierten-aminobenzyl) -propandiolen- (1,3) | |
| AT335627B (de) | Verfahren zur herstellung von neuen 3',4'-anhydro-alfa,l-talomethylosiden | |
| AT331422B (de) | Verfahren zur herstellung von neuen digitoxigenin-l-rhamnosid-cyclocarbonaten | |
| AT327206B (de) | Verfahren zur herstellung von neuen nitrochinazolinonen | |
| ATA393275A (de) | Verfahren zur herstellung von neuen 1-phenoxy-2-hydroxy-3-amino-propanen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ELJ | Ceased due to non-payment of the annual fee |